SORT1 and lung carcinoma: In the absence of comprehensive evidence of the status of sortilin in NSCLC, the aim of this study was to extensively explore the expression and DNA methylation levels of SORT1 variants in both primary NSCLC samples and normal lung tissue as well as peripheral blood and cell lines of lung cancer origin.